[go: up one dir, main page]

DE69019359D1 - Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen. - Google Patents

Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.

Info

Publication number
DE69019359D1
DE69019359D1 DE69019359T DE69019359T DE69019359D1 DE 69019359 D1 DE69019359 D1 DE 69019359D1 DE 69019359 T DE69019359 T DE 69019359T DE 69019359 T DE69019359 T DE 69019359T DE 69019359 D1 DE69019359 D1 DE 69019359D1
Authority
DE
Germany
Prior art keywords
proteins
particles
virus
vaccines
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69019359T
Other languages
English (en)
Other versions
DE69019359T3 (de
DE69019359T2 (de
Inventor
Caroline Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Leiden
Original Assignee
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19855310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69019359(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Universiteit Leiden filed Critical Universiteit Leiden
Application granted granted Critical
Publication of DE69019359D1 publication Critical patent/DE69019359D1/de
Publication of DE69019359T2 publication Critical patent/DE69019359T2/de
Publication of DE69019359T3 publication Critical patent/DE69019359T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14323—Virus like particles [VLP]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69019359T 1989-09-14 1990-09-11 Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen. Expired - Lifetime DE69019359T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL8902301 1989-09-14
NL8902301A NL8902301A (nl) 1989-09-14 1989-09-14 Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.
PCT/NL1990/000130 WO1991004330A1 (en) 1989-09-14 1990-09-11 Human parvovirus b19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines

Publications (3)

Publication Number Publication Date
DE69019359D1 true DE69019359D1 (de) 1995-06-14
DE69019359T2 DE69019359T2 (de) 1995-10-12
DE69019359T3 DE69019359T3 (de) 2006-09-07

Family

ID=19855310

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019359T Expired - Lifetime DE69019359T3 (de) 1989-09-14 1990-09-11 Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.

Country Status (7)

Country Link
EP (1) EP0491824B2 (de)
AT (1) ATE122395T1 (de)
DE (1) DE69019359T3 (de)
DK (1) DK0491824T4 (de)
ES (1) ES2073036T5 (de)
NL (1) NL8902301A (de)
WO (1) WO1991004330A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2755817B2 (ja) * 1988-11-14 1998-05-25 アメリカ合衆国 パルボウイルスキャプシド
WO1993002184A1 (en) 1991-07-19 1993-02-04 The University Of Queensland Papilloma virus vaccine
ES2048646B1 (es) * 1992-04-15 1994-10-01 Ercros Sa Procedimiento para la obtencion de la proteina vp2 del virus de la peste equina africana (ahsv)
US5437951A (en) 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
CA2175256A1 (en) * 1993-10-28 1995-05-04 Andrea Kern Adeno-associated virus - its diagnostic use with early abortion
EP0813683A1 (de) * 1995-03-08 1997-12-29 Klaus Dr. Hedman Verfahren zum nachweis von infektionen
EP0783038B1 (de) * 1996-01-02 2007-04-04 Institut Pasteur Rekombinante virale Pseudopartikeln und deren Verwendung als Impfstoff oder als antitumorale Wirkstoff
FR2771751B1 (fr) 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
SE520177C2 (sv) * 1998-11-24 2003-06-03 Kristina Broliden Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller
US6743772B1 (en) 1998-11-24 2004-06-01 Kristina Broliden Use of parovirus capsid particles in the inhibition of cell proliferation and migration
US6818612B2 (en) 1998-11-24 2004-11-16 Kristina Broliden Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
MXPA03011802A (es) 2001-06-28 2004-04-02 Chiron Corp Ensayo de diagnostico para parvovirus b19.
WO2006004173A1 (ja) 2004-07-01 2006-01-12 The Circle For The Promotion Of Science And Engineering 生理的条件下でのウイルス粒子様構造体及びその形成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine

Also Published As

Publication number Publication date
DK0491824T4 (da) 2006-05-08
ATE122395T1 (de) 1995-05-15
WO1991004330A1 (en) 1991-04-04
EP0491824B2 (de) 2006-04-12
DE69019359T3 (de) 2006-09-07
EP0491824A1 (de) 1992-07-01
DK0491824T3 (da) 1995-07-17
ES2073036T3 (es) 1995-08-01
NL8902301A (nl) 1991-04-02
EP0491824B1 (de) 1995-05-10
DE69019359T2 (de) 1995-10-12
ES2073036T5 (es) 2006-08-01

Similar Documents

Publication Publication Date Title
DE69019359D1 (de) Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
WO2002032962A3 (en) Compositions of human proteins and method of use thereof
DE69731289D1 (de) Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
DE3886506D1 (de) Avirulente mikroben und deren verwendungen.
NO20012812L (no) Vaksinesammensetning og vaksine samt anvendelse av polypeptid og polynukletid
NO902802D0 (no) Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus.
ATE516348T1 (de) Glykoprotein vi und dessen anwendungen
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
HK1053985A1 (zh) 人類多肽引起或導致殺死細胞，包括淋巴腫瘤細胞
HUP9901546A2 (hu) Helicobacter pylori antigének és vakcinakészítmények
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
ATE236980T1 (de) Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
DE3752131D1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
DE69031351D1 (de) Zubereitungen und behandlungen von pneumonia in tieren
ATE237691T1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
WO1996009391A3 (en) Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
DE60140559D1 (de) 32144, eine humane fettsäureamid-hydrolase und deren verwendungen
DE68923286D1 (de) Impfstoffe und testsätze für haemophilus influenzae.
ATE181104T1 (de) Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung
WO2002002760A3 (en) 25869, a human carboxylesterase and uses thereof
ATE480620T1 (de) Neue pgc-1-isoformen und deren verwendungen
ATE470716T1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings